These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29208691)

  • 1. Inhibition of nitric oxide synthase unmasks vigorous vasoconstriction in established pulmonary arterial hypertension.
    Tanaka M; Abe K; Oka M; Saku K; Yoshida K; Ishikawa T; McMurtry IF; Sunagawa K; Hoka S; Tsutsui H
    Physiol Rep; 2017 Dec; 5(23):. PubMed ID: 29208691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.
    Li G; Zhang H; Zhao L; Zhang Y; Yan D; Liu Y
    J Am Soc Hypertens; 2017 Dec; 11(12):842-852. PubMed ID: 29146157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.
    Christou H; Hudalla H; Michael Z; Filatava EJ; Li J; Zhu M; Possomato-Vieira JS; Dias-Junior C; Kourembanas S; Khalil RA
    J Pharmacol Exp Ther; 2018 Feb; 364(2):258-274. PubMed ID: 29212831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats.
    Oka M; Homma N; Taraseviciene-Stewart L; Morris KG; Kraskauskas D; Burns N; Voelkel NF; McMurtry IF
    Circ Res; 2007 Mar; 100(6):923-9. PubMed ID: 17332430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced hypoxic pulmonary vascular remodeling by nitric oxide from the endothelium.
    Ozaki M; Kawashima S; Yamashita T; Ohashi Y; Rikitake Y; Inoue N; Hirata KI; Hayashi Y; Itoh H; Yokoyama M
    Hypertension; 2001 Feb; 37(2):322-7. PubMed ID: 11230292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective iNOS inhibition attenuates acetylcholine- and bradykinin-induced vasoconstriction in lipopolysaccharide-exposed rat lungs.
    Fischer LG; Horstman DJ; Hahnenkamp K; Kechner NE; Rich GF
    Anesthesiology; 1999 Dec; 91(6):1724-32. PubMed ID: 10598616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Garlic elicits a nitric oxide-dependent relaxation and inhibits hypoxic pulmonary vasoconstriction in rats.
    Kim-Park S; Ku DD
    Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):780-6. PubMed ID: 11022969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hypoxia decreases arterial and venous compliance in isolated perfused rat lungs: an effect that is reversed by exogenous L-arginine.
    Jin Y; Chen B; Calvert TJ; Chicoine LG; Liu Y; Nelin LD
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H195-205. PubMed ID: 23103497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoconstriction increases pulmonary nitric oxide synthesis and circulating cyclic GMP.
    Wilson PS; Thompson WJ; Moore TM; Khimenko PL; Taylor AE
    J Surg Res; 1997 Jun; 70(1):75-83. PubMed ID: 9228932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous nitric oxide centrally enhances pulmonary reactivity in the normal and hypertensive rat.
    Schwenke DO; Pearson JT; Tsuchimochi H; Mori H; Shirai M
    Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):952-9. PubMed ID: 16405452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired NO-mediated vasodilation with increased superoxide but robust EDHF function in right ventricular arterial microvessels of pulmonary hypertensive rats.
    Kajiya M; Hirota M; Inai Y; Kiyooka T; Morimoto T; Iwasaki T; Endo K; Mohri S; Shimizu J; Yada T; Ogasawara Y; Naruse K; Ohe T; Kajiya F
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2737-44. PubMed ID: 17220192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β2-Adrenergic receptor-dependent attenuation of hypoxic pulmonary vasoconstriction prevents progression of pulmonary arterial hypertension in intermittent hypoxic rats.
    Nagai H; Kuwahira I; Schwenke DO; Tsuchimochi H; Nara A; Inagaki T; Ogura S; Fujii Y; Umetani K; Shimosawa T; Yoshida K; Pearson JT; Uemura K; Shirai M
    PLoS One; 2014; 9(10):e110693. PubMed ID: 25350545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal hemodynamic and histological progression in Sugen5416/hypoxia/normoxia-exposed pulmonary arterial hypertensive rats.
    Toba M; Alzoubi A; O'Neill KD; Gairhe S; Matsumoto Y; Oshima K; Abe K; Oka M; McMurtry IF
    Am J Physiol Heart Circ Physiol; 2014 Jan; 306(2):H243-50. PubMed ID: 24240870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Rho-kinase signaling and endothelial dysfunction in modulating blood flow distribution in pulmonary hypertension.
    Schwenke DO; Pearson JT; Sonobe T; Ishibashi-Ueda H; Shimouchi A; Kangawa K; Umetani K; Shirai M
    J Appl Physiol (1985); 2011 Apr; 110(4):901-8. PubMed ID: 21212241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of hypoxic pulmonary vasoconstriction is time and nitric oxide dependent in a peritonitis model of sepsis.
    Fischer LG; Freise H; Hilpert JH; Wendholt D; Lauer S; Van Aken H; Sielenkämper AW
    Intensive Care Med; 2004 Sep; 30(9):1821-8. PubMed ID: 15375651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced NO-dependent pulmonary vasodilation limits increased vasoconstrictor sensitivity in neonatal chronic hypoxia.
    Sheak JR; Weise-Cross L; deKay RJ; Walker BR; Jernigan NL; Resta TC
    Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H828-H838. PubMed ID: 28733445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel peptide for attenuation of hypoxia-induced pulmonary hypertension via modulation of nitric oxide release and phosphodiesterase -5 activity.
    Hu H; Zharikov S; Patel JM
    Peptides; 2012 May; 35(1):78-85. PubMed ID: 22465621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capillary Degeneration and Right Ventricular Remodeling Due to Hypoxic Stress with Sugen5416.
    Woo E; Kato R; Imano H; Fujiwara Y; Ijiri Y; Okada Y; Yamaguchi T; Izumi Y; Yoshiyama M; Katsumata T; Hayashi T
    Curr Vasc Pharmacol; 2017; 15(6):589-598. PubMed ID: 28460626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced nitric oxide impairs relaxation but not contraction in endotoxin-exposed rat pulmonary arteries.
    Boer C; Groeneveld AB; Scheffer GJ; de Lange JJ; Westerhof N; Sipkema P
    J Surg Res; 2005 Aug; 127(2):197-202. PubMed ID: 15921694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin B receptor deficiency potentiates ET-1 and hypoxic pulmonary vasoconstriction.
    Ivy D; McMurtry IF; Yanagisawa M; Gariepy CE; Le Cras TD; Gebb SA; Morris KG; Wiseman RC; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2001 May; 280(5):L1040-8. PubMed ID: 11290529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.